nodes	percent_of_prediction	percent_of_DWPC	metapath
Anileridine—Cloperastine—Dimenhydrinate—atopic dermatitis	0.504	0.527	CrCrCtD
Anileridine—Cloperastine—Diphenhydramine—atopic dermatitis	0.239	0.25	CrCrCtD
Anileridine—Fentanyl—Diphenhydramine—atopic dermatitis	0.213	0.223	CrCrCtD
Anileridine—OPRM1—IL4-mediated signaling events—FCER2—atopic dermatitis	0.0029	0.066	CbGpPWpGaD
Anileridine—OPRM1—IL4-mediated signaling events—CCL17—atopic dermatitis	0.00216	0.0491	CbGpPWpGaD
Anileridine—OPRM1—IL4-mediated signaling events—CCL11—atopic dermatitis	0.00174	0.0396	CbGpPWpGaD
Anileridine—OPRM1—IL4-mediated signaling events—STAT6—atopic dermatitis	0.00163	0.0372	CbGpPWpGaD
Anileridine—OPRM1—Peptide GPCRs—CCR3—atopic dermatitis	0.00123	0.028	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—CARD11—atopic dermatitis	0.00118	0.0269	CbGpPWpGaD
Anileridine—OPRM1—IL4-mediated signaling events—IL5—atopic dermatitis	0.00117	0.0267	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.0011	0.0251	CbGpPWpGaD
Anileridine—OPRM1—Peptide GPCRs—CXCR3—atopic dermatitis	0.00107	0.0245	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.000981	0.0223	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—IL17A—atopic dermatitis	0.000937	0.0213	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00088	0.02	CbGpPWpGaD
Anileridine—OPRM1—IL4-mediated signaling events—IL10—atopic dermatitis	0.000858	0.0195	CbGpPWpGaD
Anileridine—OPRM1—IL4-mediated signaling events—IL4—atopic dermatitis	0.000835	0.019	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CCL27—atopic dermatitis	0.000827	0.0188	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000738	0.0168	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.000709	0.0161	CbGpPWpGaD
Anileridine—OPRM1—Peptide GPCRs—CCR5—atopic dermatitis	0.000673	0.0153	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000658	0.015	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—CD8A—atopic dermatitis	0.00063	0.0143	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00059	0.0134	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000578	0.0132	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—CCR5—atopic dermatitis	0.000576	0.0131	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL22—atopic dermatitis	0.000562	0.0128	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000515	0.0117	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000515	0.0117	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000505	0.0115	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL27—atopic dermatitis	0.000501	0.0114	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.000488	0.0111	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000488	0.0111	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000476	0.0108	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000453	0.0103	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL17—atopic dermatitis	0.000449	0.0102	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000426	0.00971	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000408	0.0093	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000396	0.00901	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000388	0.00883	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	0.000362	0.00825	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	0.000362	0.00823	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000352	0.00801	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000346	0.00787	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000346	0.00787	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000345	0.00785	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000339	0.00772	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	0.000334	0.00761	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000317	0.00721	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000306	0.00697	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000297	0.00675	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	0.000295	0.00672	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	0.000288	0.00657	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000283	0.00645	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000274	0.00624	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000267	0.00608	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	0.000263	0.00599	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	0.000263	0.00599	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000258	0.00588	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	0.000257	0.00585	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000248	0.00565	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000236	0.00537	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	0.000231	0.00525	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000212	0.00484	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000209	0.00475	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	0.000196	0.00445	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000191	0.00436	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	0.000186	0.00423	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	0.000183	0.00417	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	0.00018	0.00409	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	0.00017	0.00388	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000167	0.0038	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	0.000162	0.00368	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000162	0.00368	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	0.000152	0.00346	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	0.000152	0.00345	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000149	0.00339	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	0.000149	0.00339	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000146	0.00332	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	0.000138	0.00315	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	0.000136	0.0031	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	0.000135	0.00308	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	0.000135	0.00308	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000132	0.00302	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000128	0.00293	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	0.000126	0.00286	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	0.000121	0.00277	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000118	0.00268	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	0.00011	0.0025	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	0.00011	0.0025	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000107	0.00244	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	0.000103	0.00235	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000101	0.00231	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	9.78e-05	0.00223	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	9.22e-05	0.0021	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	9.14e-05	0.00208	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	8.95e-05	0.00204	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	8.3e-05	0.00189	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NPS—atopic dermatitis	7.98e-05	0.00182	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	7.98e-05	0.00182	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	7.82e-05	0.00178	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL5—atopic dermatitis	7.42e-05	0.00169	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	6.32e-05	0.00144	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.53e-05	0.00126	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	5.44e-05	0.00124	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	5.28e-05	0.0012	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NGF—atopic dermatitis	5.04e-05	0.00115	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	5.02e-05	0.00114	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	4.9e-05	0.00112	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	4.8e-05	0.00109	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	4.16e-05	0.000947	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	2.97e-05	0.000675	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL2—atopic dermatitis	2.83e-05	0.000645	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	2.82e-05	0.000642	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	2.61e-05	0.000594	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL6—atopic dermatitis	1.67e-05	0.000379	CbGpPWpGaD
